The 2022 award goes to Dr András Lakatos from the University of Cambridge.

Dr András Lakatos is a clinician scientist and at the Department of Clinical Neurosciences, University of Cambridge. After pausing his research activities to complete his full-time clinical specialist training in general medicine and neurology, he returned to the field of neurodegeneration and dementia research. He obtained a Junior University Fellowship and later an MRC Clinician Scientist Fellowship Award in 2017, which helped him establish a successful neurobiology research group at Cambridge.

Dr Lakatos’ research has contributed towards understanding the role of non-neuronal cells in neuronal network function and degeneration through the development of state-of-the-art experimental platforms, including in vitro stem cell-derived three-dimensional human brain organoids. These discoveries also have a potential to inform the development of therapeutic approaches. He is currently leading a research team that aims to address knowledge gaps between genetic risk and initiating cellular pathways contributing to neuron and synapse loss in human frontotemporal dementia-amyotrophic lateral sclerosis (FTD/ALS) disease spectrum model systems.

Read more about him on our News page.

 

We caught up with Dr Lakatos to ask him a few questions.